Health in Saint Lucia 1,164 indicators covering health for Saint Lucia. IndicatorLatest Year10-yr change Rank Physical activity policies for activie societies 10 2023 down 50.0% 113th Physical activity policies focused on active systems 20 2023 unchanged 5th Child population under age 5 10.02 2025 down 6.1% 27th Percentage of children as a proportion of total population 21.32 2025 down 18.1% 28th Child population 10-19 22.87 2025 down 21.2% 27th Death rate from poisonings 0.1 2021 down 50.0% 158th 3.8.1 Coverage of essential health services 77 2021 up 13.2% 56th Mortality rate attributed to cardiovascular disease, cancer, diabetes 15.5 2021 down 8.3% 108th Mortality rate attributed to unintentional poisonings, by sex 0.1 2021 down 50.0% 143rd Suicide mortality rate, by sex 5.3 2021 down 30.3% 109th Share of deaths registered 98.96 2019 — 46th Affordability - percentage of GDP per capita required to purchase 3.87 2022 up 12.8% 85th Child population 38.41 2025 down 15.7% 27th Deaths and missing persons due to natural disasters 2.88 2013 up 380.0% 44th Mean systolic blood pressure 124.8 2009 up 0.6% 104th Mean fasting blood glucose (mmol/l) 5.6 2009 up 5.7% 30th Number of pregnant women living with HIV who received antiretrovirals 7 2025 up 75.0% 100th Hiv expenditure 257,787 2024 up 132.0% 91st Number of new leprosy cases with G2D among children 0 2024 — 35th Life expectancy at birth 73 2025 up 0.1% 26th Most sold brand of cigarettes - price in currency reported 8.95 2020 up 37.7% 137th Most sold brand of cigarettes - taxes as a % of price - total tax 0.5% 2020 up 88.9% 106th Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.0% 2020 down 100.0% 109th Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 — 34th Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 down 50.0% 32nd Most sold brand of cigarettes - taxes as a % of price - value added 0.1% 2020 — 107th Most sold brand of cigarettes - taxes as a % of price - specific 0.4% 2020 — 47th Most sold brand of cigarettes - price in US$ at official exchange 3.31 2020 up 37.3% 83rd Number healthy diet unaffordable 0 2024 — 138th Import of environmentally sound technologies 34.19 million 2019 up 22.6% 156th Percentage of people living with HIV who know their HIV status 93 2024 up 3.3% 30th Percentage of people living with HIV who know their status receiving 47 2024 down 6.0% 125th Most sold brand of cigarettes - price in PPP$ 4.65 2020 up 32.1% 112th Export of environmentally sound technologies 1.47 million 2019 down 62.9% 146th Reported number of human rabies deaths 0 2024 — 62nd Proportion of births delivered in a health facility (Facility births) 99.0% 2022 down 1.0% 39th Number of non-autochthonous leprosy cases 1 2024 — 36th Maternal mortality ratio 52.1 2021 up 4.6% 26th Population with basic handwashing facilities at home 87.2% 2016 unchanged 28th Under-five mortality rate - SDG 3.2.1 17.24 2024 down 8.3% 10th Infant mortality rate - SDG 3.2.1 15.84 2024 down 6.3% 10th Number of under-five deaths - SDG 3.2.1 35 2024 down 14.6% 26th Neonatal mortality rate - SDG 3.2.2 11.25 2024 down 17.3% 9th HPV immunization coverage estimates among primary target cohort (9-14) 89.0% 2025 up 12.7% 24th Tuberculosis - new and relapse cases 7 2011 down 53.3% 181st Pregnant women receiving prenatal care 96.9% 2012 up 102.7% 42nd Average of 13 International Health Regulations core capacity scores 77 2016 up 165.5% 72nd New cases: pulmonary smear-negative 0 2012 down 100.0% 182nd Average death rate due to natural disasters 0 2014 — 111th Total number of notified TB cases 6 2014 down 60.0% 182nd The number of people with susceptibility test result for rifampicin 2 2021 — 143rd Number of deaths caused by intentional injuries 50 2020 up 13.6% 22nd Mortality rate 5.59 2024 up 71.7% 5th Neonatal deaths 0.6571 2024 down 7.1% 11th New cases: pulmonary smear unknown/not done 0 2012 — 109th Smear-positive tuberculosis treatment-success rate 57.0% 2011 up 14.0% 169th Insufficiently active 84.34 2016 down 0.1% 60th The number of people with susceptibility test result for rifampicin 100 2021 — 2nd Retreatment cases: treatment after default 0 2012 — 126th Retreatment cases: other 0 2012 down 100.0% 123rd ← Previous Page 18 of 20 Next →